Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (271-280 of 372) with videos related to

Pageof 38
Sort By:
Journal of Cardiovascular Translational Research|February 16, 2023
Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection FractionKoen W Streng, Hans L Hillege, Jozine M Ter Maaten, et al.
European Journal of Heart Failure|March 28, 2023
Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HFDimitrios Farmakis, Jasper Tromp, Smaragdi Marinaki, et al.
ESC Heart Failure|May 17, 2021
Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fractionFraser M Curran, U Bhalraam, Mohapradeep Mohan, et al.
European Heart Journal|April 8, 2022
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fractionJasper Tromp, Wouter Ouwerkerk, Tiew-Hwa K Teng, et al.
ESC Heart Failure|March 14, 2020
Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failureMasatake Kobayashi, Susan Stienen, Jozine M Ter Maaten, et al.
Circulation. Heart Failure|May 17, 2019
Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart FailureJohanna E Emmens, Jozine M Ter Maaten, Kevin Damman, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2022
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failureMatteo Pagnesi, Marianna Adamo, Iziah E Sama, et al.
European Journal of Heart Failure|March 2, 2017
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failureAdriaan A Voors, Wouter Ouwerkerk, Faiez Zannad, et al.
European Journal of Heart Failure|May 21, 2022
Distinct pathophysiological pathways in women and men with heart failureAlice Ravera, Bernadet T Santema, Rudolf A de Boer, et al.
European Journal of Heart Failure|April 24, 2009
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of CardiologyTiny Jaarsma, James M Beattie, Mary Ryder, et al.
Pageof 38

Showing results (271-280 of 372) with videos related to

Sort By:
Pageof 38
Journal of Cardiovascular Translational Research|February 16, 2023
Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection FractionKoen W Streng, Hans L Hillege, Jozine M Ter Maaten, et al.
European Journal of Heart Failure|March 28, 2023
Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HFDimitrios Farmakis, Jasper Tromp, Smaragdi Marinaki, et al.
ESC Heart Failure|May 17, 2021
Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fractionFraser M Curran, U Bhalraam, Mohapradeep Mohan, et al.
European Heart Journal|April 8, 2022
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fractionJasper Tromp, Wouter Ouwerkerk, Tiew-Hwa K Teng, et al.
ESC Heart Failure|March 14, 2020
Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failureMasatake Kobayashi, Susan Stienen, Jozine M Ter Maaten, et al.
Circulation. Heart Failure|May 17, 2019
Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart FailureJohanna E Emmens, Jozine M Ter Maaten, Kevin Damman, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2022
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failureMatteo Pagnesi, Marianna Adamo, Iziah E Sama, et al.
European Journal of Heart Failure|March 2, 2017
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failureAdriaan A Voors, Wouter Ouwerkerk, Faiez Zannad, et al.
European Journal of Heart Failure|May 21, 2022
Distinct pathophysiological pathways in women and men with heart failureAlice Ravera, Bernadet T Santema, Rudolf A de Boer, et al.
European Journal of Heart Failure|April 24, 2009
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of CardiologyTiny Jaarsma, James M Beattie, Mary Ryder, et al.
Pageof 38